2025 (3 publications, total IF 31.5)

Clinical advances of mRNA vaccines for cancer immunotherapy.
AV Yaremenko, MM Khan, X Zhen, Y Tang, W Tao. Med (Cell Press), 2025, 6 (1). (IF 12.8)

Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors.
IB Belyaev, OY Griaznova, AV Yaremenko, SM Deyev, IV Zelepukin. Advanced Drug Delivery Reviews, 2025, 115550. (IF 15.3)

Pre-Clinical and Clinical Advances in Gene Therapy of X-Linked Retinitis Pigmentosa: Hope on the Horizon.
NA Pechnikova, M Poimenidou, I Iliadis, M Zafeiriou-Chatziefraimidou, AV Iaremenko, TV Yaremenko, K Domvri, AV Yaremenko*. Journal of Clinical Medicine, 2025, 14 (3), 898. (IF 3.4)

2024 (6 publications, total IF 63.3)

Implantable Biomaterials for Cancer Immunotherapies.
NA Pechnikova, A Aggeli, AA Latypova, AV Iaremenko, K Domvri, IV Zubarev, C Liu, AV Yaremenko*. Advanced Functional Materials, 2024, 2416813. (IF 18.5)

Modification of Contact Lenses via Metal-Organic Frameworks for Glaucoma Treatment.
A.V. Yaremenko*, R.O. Melikov, N.A. Pechnikova, I.B. Belyaev, Alina Ringaci, T.V. Yaremenko, A.B. et. al. Aggregate, 2024, e586. (IF 13.9)

Carbon Quantum Dots in Biomedical Applications: Advances, Challenges, and Future Prospects.
NA Pechnikova, K Domvri, K Porpodis, MS Istomina, AV Iaremenko, AV Yaremenko*. Aggregate, 2024, e707. (IF 13.9)

Magnetogenetics as a Promising Tool for Controlling Cellular Signaling Pathways.
AA Latypova, AV Yaremenko*, N.A. Pechnikova, A.S. Minin, I.V. Zubarev#. Journal of Nanobiotechnology, 2024, 22(1) 327. (IF 10.6)

Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction.
K Domvri, AV Yaremenko*, A Apostolopoulos, S Petanidis, et. al. Heliyon, 2024, 10 (5). (IF 3.4)

Association of Fetal Lung Development Disorders with Adult Diseases: A Comprehensive Review.
AV Yaremenko*, NA Pechnikova, K Porpodis, S Damdoumis, A Aggeli, P Theodora, K Domvri. Journal of Personalized Medicine, 2024, 14(4), 368. (IF 3.0)

2023 (1 publication, IF 21.1)

Oral drug delivery platforms for biomedical applications.
J Ouyang, Z Zhang, B Deng, J Liu, L Wang, H Liu, S Koo, S Chen, Y Li, AV Yaremenko, X Huang, W Chen, Y Lee, W Tao. Materials Today, 2023, 62: 296-326. (IF 21.1)

2022 (4 publications, total IF 61.9)

The marriage of xenes and hydrogels: fundamentals, applications, and outlook.
Y Kang, H Zhang, L Chen, J Dong, B Yao, X Yuan, D Qin, AV Yaremenko, C Liu, C Feng, X Ji, W Tao. The Innovation, 2022, 3(6): 100327. (IF 33.2)

Cancer nanomedicine towards clinical translation: obstacles, opportunities, and future prospects.
P Zhang, Y Xiao, X Sun, X Lin, S Koo, AV Yaremenko, D Qin, N Kong, OC Farokhzad, W Tao. Med, 2022, 4(3): 147-167. (IF 12.8)

Influence of magnetic nanoparticle biotransformation on contrasting efficiency and iron metabolism.
AV Yaremenko*, IV Zelepukin, IN Ivanov, RO Melikov, NA Pechnikova, et. al. Journal of Nanobiotechnology, 2022, 20(1): 1–15. (IF 10.6)

Macrophage blockade using nature-inspired ferrihydrite for enhanced nanoparticle delivery to tumor.
AB Mirkasymov, IV Zelepukin, IN Ivanov, IB Belyaev, DSh Dzhalilova, DB Trushina, AV Yaremenko, et.al. International Journal of Pharmaceutics, 2022, 621: 121795. (IF 5.3)

2021 (2 publications, total IF 29.1)

Long-term fate of magnetic particles in mice: A comprehensive study.
IV Zelepukin, AV Yaremenko, MV Yuryev, IN Ivanov, VR Cherkasov, SM Deyev, PI Nikitin, MP Nikitin. ACS Nano, 2021, 15(7): 11341–11357. (IF 15.8)

Metal-organic frameworks for simultaneous gene and small molecule delivery in vitro and in vivo.
A Ringaci, AV Yaremenko, KG Shevchenko, SD Zvereva, MP Nikitin. Chemical Engineering Journal, 2021, 418: 129386. (IF 13.3)

2020 (1 publication, IF 10.5)

Fast processes of nanoparticle blood clearance: comprehensive study.
IV Zelepukin, AV Yaremenko, MV Yuryev, AB Mirkasymov, IL Sokolov, SM Deyev, PI Nikitin, MP Nikitin. Journal of Controlled Release, 2020, 326:181-191. (IF 10.5)

2019 (2 publications, total IF 8.7)

Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth.
IV Zelepukin, AV Yaremenko, VO Shipunova, AV Babenyshev, IV Balalaeva, PI Nikitin, SM Deyev, MP Nikitin. Nanoscale, 2019, 11, 1636–1646. (IF 5.8)

Magnetometry-based method for investigation of nanoparticle clearance from circulation in a liver perfusion model.
IV Zelepukin, AV Yaremenko, EV Petersen, SM Deyev, VR Cherkasov, PI Nikitin, MP Nikitin. Nanotechnology, 2019, 30(10):105101. (IF 2.9)

*corresponding author
Totally 19 papers, total IF 226.1